Christopher Durant Turner - Jul 28, 2021 Form 3 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Medical Officer
Signature
/s/ Alexandra Balcom, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
3
Date filed
7/28/2021, 09:30 PM
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NUVL Stock Option (Right to Buy) Jul 28, 2021 Class A Common Stock 341K $6.89 Direct F1
holding NUVL Stock Option (Right to Buy) Jul 28, 2021 Class A Common Stock 2.84K $6.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as follows: 25% of the shares vest on March 22, 2022 and the remainder vest over the next three years in equal monthly installments, subject to continued service to the Company through the applicable vesting date.
F2 The shares underlying this option vest as follows: 25% of the shares vest on April 29, 2022 and the remainder vest over the next three years in equal monthly installments, subject to continued service to the Company through the applicable vesting date.

Remarks:

Exhibit 24: Power of Attorney